Current therapeutic developments in atrophic age-related macular degeneration - Wikidata - awgldk - TriplyDB

Current therapeutic developments in atrophic age-related macular degeneration

Current therapeutic developments in atrophic age-related macular degeneration

http://www.wikidata.org/entity/Q26778247

about

Norbixin Protects Retinal Pigmented Epithelium Cells and Photoreceptors against A2E-Mediated Phototoxicity In Vitro and In Vivo Oxidative stress affects retinal pigment epithelial cell survival through epidermal growth factor receptor/AKT signaling pathway.Timing of Antioxidant Gene Therapy: Implications for Treating Dry AMD.Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.Photoprotective effects of cranberry juice and its various fractions against blue light-induced impairment in human retinal pigment epithelial cells.Advances in bone marrow stem cell therapy for retinal dysfunction.The formation of a functional retinal pigment epithelium occurs on porous polytetrafluoroethylene substrates independently of the surface chemistry.Neurotransmitter-Regulated Regeneration in the Zebrafish Retina.Nonhuman Primate Studies to Advance Vision Science and Prevent Blindness.Efficacy of a Fatty Acids Dietary Supplement in a Polyethylene Glycol-Induced Mouse Model of Retinal Degeneration.Age-Related Macular Degeneration: New Paradigms for Treatment and Management of AMD.Expression and regulation of alarmin cytokine IL-1α in human retinal pigment epithelial cells.[Atrophy of the macula in the context of its wet, age-related degeneration : An inescapable consequence of anti-VEGF therapy?]Characterization of Rod Function Phenotypes Across a Range of Age-Related Macular Degeneration Severities and Subretinal Drusenoid Deposits.

P2860

Q28555093-C7DF058E-AC43-4559-8417-F1EE956A3B25 Q33607708-D41A94B2-C573-4317-8480-47A2385A7C07 Q37682509-8C8FAB0C-90B7-436D-8B2D-729FE4FF113F Q38653249-9F6FC60B-3137-4DC9-A804-CB326652A4D5 Q38726883-646DF3F3-BE30-4D0B-9533-28BB420C8847 Q38804673-0A2BF9AE-B402-458E-9982-35DFD7BB2EE8 Q41010885-6D8B143B-D722-4AE8-9D38-B82555007258 Q42291768-F1FF2109-9F30-485E-B60B-9E4EA8D3BD31 Q45868488-D6F9E85B-9CB3-4E6A-9278-9F901C80C5FD Q47124297-56D9834E-E86D-4CAF-B47A-8C59AFCBABA6 Q50332949-52D77F6F-838E-4417-8490-8657CD39F32C Q52351407-7AC66806-D249-4A6B-8593-3458239826DC Q53018746-E76F2F7F-EDEC-4068-BDDC-A95EF79B175A Q54960105-999E3AE8-0B33-49F7-92F9-1F3A424BB7DB

P2860

Current therapeutic developments in atrophic age-related macular degeneration

http://www.wikidata.org/entity/Q26778247

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Current therapeutic developments in atrophic age-related macular degeneration

@ast

Current therapeutic developments in atrophic age-related macular degeneration

@en

Current therapeutic developments in atrophic age-related macular degeneration

@nl

type

label

Current therapeutic developments in atrophic age-related macular degeneration

@ast

Current therapeutic developments in atrophic age-related macular degeneration

@en

Current therapeutic developments in atrophic age-related macular degeneration

@nl

prefLabel

Current therapeutic developments in atrophic age-related macular degeneration

@ast

Current therapeutic developments in atrophic age-related macular degeneration

@en

Current therapeutic developments in atrophic age-related macular degeneration

@nl

P1433

Q26778247-50047263-8667-486D-940A-6952756BEDBA

P1476

Q26778247-413FCE53-95BE-451B-AB1B-D1AA687754BB

P2093

Q26778247-3DE22317-BDD0-44B6-B7D5-910615BB35EE

Q26778247-71CCDDD1-C011-4607-98DC-E2A429E7D37D

Q26778247-7E44CA75-3D5A-4F59-9280-EEF5A5BBCA4A

P2860

Q26778247-01930ECB-7CE8-46BB-AFF0-BE525429DF98

Q26778247-04DF4791-4C58-478B-A84F-9D335EE1213C

Q26778247-0CBE658D-F943-4DD8-AF38-C0419CCD6701

Q26778247-1171354F-6B19-4844-995B-74E05B276403

Q26778247-1590D36A-E438-463E-A9BC-58F00EE702D3

Q26778247-1914925D-947F-4F16-8558-227B0A5FC647

Q26778247-2178E1B4-062F-4CF9-8717-308935C782DD

Q26778247-2AAF0E0C-0409-4D5E-BD51-BF9BF7201D22

Q26778247-2FF86F95-0C55-48F9-8851-03DBED4307F4

Q26778247-3C998E26-CFFC-4924-83E0-E5B319C8914D

P304

Q26778247-231CC99E-BF17-4386-8424-8C577DC39207

P31

Q26778247-A2AEBFBA-4090-4296-A64D-7ABE921FC3E4

P356

Q26778247-36BC0AC9-E413-4F9E-9089-58262DBF7DDF

P407

Q26778247-E4FAC809-6FE8-4340-AF83-8263B5C4A44C

P433

Q26778247-F079A11B-2719-4393-A743-AAA8A193874A

P478

Q26778247-75CF8585-8CC8-470A-855A-752940144BDE

P577

Q26778247-205D4ACF-8DE3-4568-A3DC-AE01090BC65D

P5875

Q26778247-B47D796B-6195-4C14-8D37-4D9895DC8EE4

P698

Q26778247-9BCACF31-9F58-4988-AB64-A425E2169D16

P932

Q26778247-4E67CD95-F5B8-4BAA-BF33-8F62F8CB065B

P356

BJOPHTHALMOL-2015-306972

P1433

British Journal of Ophthalmology

P1476

Current therapeutic developments in atrophic age-related macular degeneration

@en

P2093

Fangkun Zhao

http://www.w3.org/2001/XMLSchema#string

Jakub Hanus

http://www.w3.org/2001/XMLSchema#string

Shusheng Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular characterization and functional analysis of phagocytosis by human embryonic stem cell-derived RPE cells using a novel human retinal assay

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

Complement factor H polymorphism in age-related macular degeneration

mTOR signaling in growth control and disease

Complement factor H variant increases the risk of age-related macular degeneration

Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies

Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial

Direct isolation of human central nervous system stem cells

Reductions in Serum Vitamin A Arrest Accumulation of Toxic Retinal Fluorophores: A Potential Therapy for Treatment of Lipofuscin-Based Retinal Diseases

Complement factor H polymorphism and age-related macular degeneration

P304

122-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BJOPHTHALMOL-2015-306972

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283651563

http://www.w3.org/2001/XMLSchema#string

P698

26553922

http://www.w3.org/2001/XMLSchema#string

P932

4944382

http://www.w3.org/2001/XMLSchema#string